These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17872357)

  • 1. Current controversy related to glucocorticoid and insulin therapy in the intensive care unit.
    Klaff LS; Wisse BE
    Endocr Pract; 2007 Sep; 13(5):542-9. PubMed ID: 17872357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?
    Okabayashi T; Shima Y
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):190-9. PubMed ID: 24378668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight glucose control in critically ill children--a systematic review and meta-analysis.
    Srinivasan V; Agus MS
    Pediatr Diabetes; 2014 Mar; 15(2):75-83. PubMed ID: 24783254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of intensive insulin therapy on the mortality of critically ill patients in intensive care unit: a meta-analysis].
    Li J; Li L; Ma B; Yang KH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):349-52. PubMed ID: 19570341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive insulin therapy in the intensive care unit, hypoglycemia, and cardiovascular mortality.
    Rana O; Byrne CD; Greaves K
    Hosp Pract (1995); 2010 Apr; 38(2):59-66. PubMed ID: 20469614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin therapy for the critically ill patient.
    Van den Berghe G
    Clin Cornerstone; 2003; 5(2):56-63. PubMed ID: 12800480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.
    Van den Berghe G; Wilmer A; Milants I; Wouters PJ; Bouckaert B; Bruyninckx F; Bouillon R; Schetz M
    Diabetes; 2006 Nov; 55(11):3151-9. PubMed ID: 17065355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis.
    Shan L; Hao PP; Chen YG
    J Trauma; 2011 Nov; 71(5):1460-4. PubMed ID: 22071938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating hyperglycemia in neurocritical patients: benefits and perils.
    Godoy DA; Di Napoli M; Rabinstein AA
    Neurocrit Care; 2010 Dec; 13(3):425-38. PubMed ID: 20652767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intravenous insulin therapy in critically ill patients.
    Van den Berghe GH
    Endocr Pract; 2004; 10 Suppl 2():17-20. PubMed ID: 15251636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
    Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy in hospitalized patients: a systematic review.
    Kansagara D; Fu R; Freeman M; Wolf F; Helfand M
    Ann Intern Med; 2011 Feb; 154(4):268-82. PubMed ID: 21320942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients.
    Mesotten D; Wauters J; Van den Berghe G; Wouters PJ; Milants I; Wilmer A
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2345-52. PubMed ID: 19366849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study.
    Hermans G; Schrooten M; Van Damme P; Berends N; Bouckaert B; De Vooght W; Robberecht W; Van den Berghe G
    Crit Care; 2009; 13(1):R5. PubMed ID: 19166623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
    Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
    Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the treatment of sepsis.
    Sandrock CE; Albertson TE
    Semin Respir Crit Care Med; 2010 Feb; 31(1):66-78. PubMed ID: 20101549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control and nutritional strategies in the cardiothoracic surgical intensive care unit--2010: state of the art.
    Mechanick JI; Scurlock C
    Semin Thorac Cardiovasc Surg; 2010; 22(3):230-5. PubMed ID: 21167457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control in critically ill patients before and after institution of an intensive insulin infusion protocol: circadian rhythm and the quality duration calculator.
    Keene A; Hailpern S; Anees S; Sandhu J; Harris M; Ashton L; Bellin E
    J Intensive Care Med; 2010; 25(1):31-8. PubMed ID: 20034953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.